|
WO2021023272A1
|
|
Crystalline form of atr inhibitor and use thereof
|
|
WO2020233694A1
|
|
Crystal form of pyrimidine sulfonamide compound and preparation method therefor
|
|
WO2020221358A1
|
|
Crystal form of wee1 inhibitor compound and use thereof
|
|
WO2019144970A1
|
|
Crystal form of 1h-imidazo[4,5-b]pyridine-2(3h)-one compound and preparation method therefor
|
|
CA3083019A1
|
|
Pyrimidine sulfamide derivative and preparation method and medical application thereof
|
|
EP3712150A1
|
|
Macrocyclic compound serving as wee1 inhibitor and applications thereof
|
|
WO2019072236A1
|
|
Crystal form and salt form of pyridone compound and preparation method therefor
|
|
US2020017528A1
|
|
1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitor
|
|
CN109661395A
|
|
PDE4 inhibitor
|
|
KR20190029729A
|
|
S1P1 agonists and their applications
|
